Don’t miss the latest developments in business and finance.

Anuh Pharma intimates of suspension of Pyrazinamide and Sulfadoxine from the WHO list of prequalified APIs

Image
Capital Market
Last Updated : Apr 21 2016 | 5:47 PM IST

Following EDQM suspension

Anuh Pharma announced that in view of the EDQM suspension, the WHO PQ authorities have suspended Pyrazinamide and Sulfadoxine from the WHO list of prequalified APIs until the WHO led inspection.

Powered by Capital Market - Live News

More From This Section

First Published: Apr 21 2016 | 12:55 PM IST

Next Story